论文部分内容阅读
目的:对吸入性布地奈德治疗毛细支气管炎效果进行临床探讨,以求寻找并完善治疗效果较好的治疗方式。方法:选取2013年2月~2014年2月期间在我院接受治疗的毛细支气管炎患者50例,随机分两组,每组25例,为观察组与对照组。观察组在常规治疗基础上服用布地奈德,对照组则给予常规治疗。观察治疗后症状体征持续时间;治疗效果。结果:观察组发热持续时间为(4.32±1.21)天,咳嗽持续时间(4.76±1.27)天,肺部啰音消失时间(4.63±1.32)天,喘息持续时间(5.24±1.41)天。对照组发热持续时间为(6.78±1.47)天,咳嗽持续时间(7.01±1.51)天,肺部啰音消失时间(7.21±1.59)天,喘息持续时间(7.83±1.58)天。观察组症状体征,包括发热持续时间,咳嗽持续时间,肺部啰音消失时间,喘息持续时间,均明显短于对照组。观察组治疗有效率为92.00%,对照组治疗有效率为64.00%。结论:布地奈德可以有效的改善毛细支气管炎症状体征,提高治疗效果。值得推广。
OBJECTIVE: To investigate the therapeutic effect of inhaled budesonide on bronchiolitis in order to find and improve the treatment with better therapeutic effect. Methods: Fifty patients with bronchiolitis who were treated in our hospital from February 2013 to February 2014 were randomly divided into two groups (n = 25 in each group), the observation group and the control group. The observation group took budesonide on the basis of routine treatment, while the control group received routine treatment. Observe the duration of symptoms and signs after treatment; treatment effect. Results: The duration of fever in observation group was (4.32 ± 1.21) days, cough duration (4.76 ± 1.27) days, lung rales disappearance time (4.63 ± 1.32) days and wheezing duration (5.24 ± 1.41) days. The duration of fever in control group was (6.78 ± 1.47) days, duration of cough was (7.01 ± 1.51) days, pulmonary rales disappeared (7.21 ± 1.59) days and wheezing duration (7.83 ± 1.58) days. Symptoms and signs of the observation group, including the duration of fever, cough duration, pulmonary rales disappeared time, wheezing duration, were significantly shorter than the control group. Observation group, the effective rate was 92.00%, the control group, the effective rate was 64.00%. Conclusion: Budesonide can effectively improve the symptoms and signs of bronchiolitis and improve the therapeutic effect. Worth promoting.